ROCHE 0245 ROCHE 0245 (Invirase 200 mg)

Generic Name: saquinavir

Pill imprint ROCHE 0245 ROCHE 0245 has been identified as Invirase 200 mg.

Invirase is used in the treatment of hiv infection; nonoccupational exposure and belongs to the drug class protease inhibitors. There is no proven risk in humans during pregnancy. Invirase 200 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for ROCHE 0245 ROCHE 0245

Invirase 200 mg ROCHE 0245 ROCHE 0245
Invirase
Generic Name:
saquinavir
Imprint:
ROCHE 0245
ROCHE 0245
Strength:
200 mg
Color:
Green / Yellow
Size:
22.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Protease inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Roche Laboratories
National Drug Code (NDC):
00004-0245
Inactive Ingredients:
lactose anhydrous
microcrystalline cellulose
povidone k30
sodium starch glycolate type A potato
magnesium silicate
magnesium stearate
gelatin
water
ferric oxide red
ferric oxide yellow
ferrosoferric oxide
FD&C Blue No. 2
titanium dioxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54868-3699 Physicians Total Care Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web5)